Montelukast

Drug Levels and Effects:




Summary of Use during Lactation:


No published information is available on the use of montelukast during breastfeeding. If montelukast is required by the mother, it is not a reason to discontinue breastfeeding. Because there is no published experience with montelukast during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Montelukast is approved for use in children as young as 6 months of age.


Drug Levels:


Maternal Levels.

Relevant published information was not found as of the revision date.

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Relevant published information was not found as of the revision date.


Possible Effects on Lactation:


Relevant published information was not found as of the revision date.


Alternate Drugs to Consider:


Beclomethasone,Cromolyn,Terbutaline,Theophylline,Zafirlukast


References:






Substance Identification:




Substance Name:

Montelukast

CAS Registry Number:

158966-92-8

Drug Class:


  • Anti-Asthmatic Agents

  • Leukotriene Antagonists


  • Administrative Information:




    LactMed Record Number:


    600


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.